Investor Create sustained value increase for investors Home>Investor Announcements and Circulars Learn More 05-23 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 05-21 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 05-20 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 05-17 2019 OVERSEAS REGULATORY ANNOUNCEMENT (H SHARES) 05-10 2019 ANNOUNCEMENT - ELECTION OF EMPLOYEE REPRESENTATIVE SUPERVISOR (H SHARES) Govemance Learn More 04-29 2019 Articles of Association 12-27 2018 Board Diversity Policy 12-27 2018 Terms of Reference and Implementation Rules of the Nomination Committee under the Board of Directors 12-27 2018 Terms of Reference and Implementation Rules of the Audit Committee under the Board of Directors 10-30 2012 Terms of Reference and Implementation Rules of the Strategic Committee under the Board of Directors Stock Info 600196-SH 18.7 0.120.64% 02196-HK 26.25 0.150.57% Reports 2019 FIRST QUARTERLY REPORT (H SHARES) 2018 Corporate Social Responsibility Report Investor Contact Contact: Li Xinlei Tel：+86-21-33987870 Fax：+86-21-33987020 Mail：ir@fosunpharma.com lixinlei@fosunpharma.com